Specialty Pharmacy
Access essential resources on specialty pharmacy to optimize patient care and operational efficiency. Explore the latest trends, best practices, and innovations in managing high-cost, high-complexity medications.
AMCP and Omnicom Health Market Access, are pleased to announce that three Precision Medicine-related articles, co-authored by AMCP and Omnicom Health Market Access team members, have been accepted for publication in the Journal of Managed Care & Specialty Pharmacy (JMCP). The articles represent a significant contribution to advancing standardization in how precision medicine is managed across the market access landscape.
View this student pharmacist session to learn from cell and gene therapy and managed care experts about their impact on healthcare, and other important aspects of these revolutionary medications!
On December 4, 2024, the Centers for Medicare and Medicaid Services (CMS) announced that two drug manufacturers of gene therapies for sickle cell disease have entered into agreements to participate in the Cell and Gene Therapy Access Model (CGT Access Model).
The FDA continues to approve novel therapies, but concerns arise due to the costs of certain treatments. To address this, the AMCP organized a forum to explore solutions. Stakeholders recognize the benefits of high-investment medications, but uptake of payment strategies has been slow. Gradual changes, education, and collaboration are essential to improve predictability, affordability, and accessibility for patients.
AMCP student webinar that described the characteristics of specialty medications and some of the unique aspects of this category, including a discussion on biosimilars, benefit design challenges, and introductory specialty channel management.
AMCP student webinar that described the characteristics of specialty medications and some of the unique aspects of this category, including a discussion on biosimilars, benefit design challenges, and introductory specialty channel management.
AMCP student webinar that described the characteristics of specialty medications and some of the unique aspects of this category, including a discussion on biosimilars, benefit design challenges, and introductory specialty channel management.
AMCP webinar that reviewed proceedings from this Partnership Forum.
